American Society of Clinical Oncology

ASCO Medical Oncology In-Training Examination

A low-stakes self-evaluation and programme-improvement assessment; it has no pass/fail certification. Irish Medical Oncology HST trainees should sit it at least once, preferably annually. The ESMO examination is a separate recommended assessment.

1
Components
2
Dates listed

Examining body: American Society of Clinical Oncology

Who can sit it

Trainees first update their ASCO account and obtain Member-in-Training membership; programme administrators then complete enrolment. Follow ASCO’s two-stage registration instructions.

When NCHDs sit it

At least once during Irish HST, preferably annually. The 2027 administration is 23–24 February; registration opens in November 2026.

Exam format

MedOnc ITE
200 questions, internet-based and proctored through the trainee’s institution; choose one day of the two-day window. · 6 hours

Dates

  • 1 Feb 2027Apply by2027 registration closes (MedOnc ITE)
  • 23 Feb 2027SittingMedOnc ITE 2027 window opens (23–24 February; choose one day) (MedOnc ITE)

Training links

HST Medical Oncology

Required to sit. Sit at least once during HST, preferably annually. This is an assessment of progress during training.

Preparation resources

College guidance, question banks, books and courses, grouped by format. Descriptions identify their coverage; provider pages give current prices and access terms.

College guidance

Check the provider for current prices and access terms. No affiliate links.

Preparing

Use the ASCO/ESMO Global Curriculum to structure learning and discuss the ITE feedback with your trainer. Review the official registration guide and proctor arrangements. ASCO describes the assessment as a snapshot of knowledge, not an individual board certification.

Facts last verified 2026-10-25.